Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
5.92
+0.04 (0.68%)
At close: Jul 13, 2026, 4:00 PM EDT
5.92
0.00 (0.00%)
After-hours: Jul 13, 2026, 4:10 PM EDT
Evolent Health Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Evolent Health stock has a consensus rating of "Buy" and an average price target of $5.88. The average 1-year stock price forecast is 0.68% lower than the current stock price, while the lowest is $3.00 (-49.32%) and the highest is $8.00 (+35.14%).
Price Target: $5.88 (-0.68%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Evolent Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 10 | 8 | 8 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Hold Downgrades $7 | Hold | Downgrades | $7 | +18.24% | Jun 30, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
| Citi | Citi | Buy Maintains $4 → $5.5 | Buy | Maintains | $4 → $5.5 | -7.09% | May 15, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +1.35% | May 12, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | +35.14% | May 11, 2026 |
Financial Forecast
Revenue This Year
2.50B
from 1.88B
Increased by 33.32%
Revenue Next Year
2.94B
from 2.50B
Increased by 17.47%
EPS This Year
0.20
from 0.09
Increased by 118.38%
EPS Next Year
0.38
from 0.20
Increased by 95.84%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.6B | ||
| Avg | 2.5B | ||
| Low | 2.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 39.2% | ||
| Avg | 33.3% | ||
| Low | 29.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.26 | ||
| Avg | 0.20 | ||
| Low | 0.13 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 188.9% | ||
| Avg | 118.4% | ||
| Low | 44.4% |